Navigation Links
EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD
Date:11/5/2007

OAK BROOK, Ill., Nov. 5 /PRNewswire/ -- EPI-Q, Inc., a consulting firm providing outcomes research and health economics services to the global biopharmaceutical and healthcare industries, announces the addition of Anthony J. Vita, MD, MPH and Peter Herout, PharmD to their team of clinical professionals. The specialized background of these two practitioners will augment the capabilities EPI-Q is able to offer directly to those clients seeking to enhance the clinical outcomes and cost-effectiveness of patient care.

Both Dr. Herout and Dr. Vita will be responsible for providing clinical support and managing projects within their fields of clinical expertise. "Peter has significant expertise in critical care and cardiology adding to our ability to provide services to hospitals and managed care in both of these important areas. Anthony has clinical skills in mental health, a therapeutic category in which EPI-Q's business is rapidly expanding and his public health training provides additional depth to our methods group," stated EPI-Q President, Mark Jewell.

Dr. Herout has over 8 years experience as a clinical pharmacist. He has spent the majority of his professional career caring for a variety of critically ill patient populations. His most recent practice and research interests have included severe trauma, cardiothoracic surgery, sepsis, glycemic control, infectious diseases, renal replacement therapy, and nutrition support. Before joining EPI-Q, Dr. Herout spent 4 years with Advocate Christ Medical Center in Oak Lawn, Illinois. His contributions to the medical literature have included articles published in Critical Care Medicine and the American Journal of Health-System Pharmacy. He received his PharmD degree from the University of Illinois at Chicago, and completed one-year ASHP-accredited residencies in Pharmacy Practice and Critical Care.

Prior to joining EPI-Q, Dr. Vita worked as a resident physician at the University of Chicago, Department of Psychiatry for 3 years. He has also practiced in a variety of hospital settings including ICU, CCU, general medicine, general pediatrics, pediatric ICU, obstetrics, and neurology. Among the journals publishing Dr. Vita's works are The New England Journal of Medicine, The Journal of Pharmacology and Experimental Therapeutics, and The American Journal of Physiology. Dr. Vita received his Doctor of Medicine degree from Stanford University and Master of Public Health degree from Harvard University.

EPI-Q, Inc. (http://www.epi-q.com) provides life sciences companies and healthcare providers and payer organizations with evidence-based solutions that elucidate the value of medical technology and improve health outcomes and cost-effectiveness. EPI-Q's professionals have extensive expertise in medicine, pharmacy, epidemiology, biostatistics, economics, business and healthcare administration. In addition, many of these experts maintain academic affiliations, publish and present frequently on issues pertaining to quality improvement and outcomes management.

Contacts:

Mark Jewell, PhD Andrew M. Baker

President Vice President - Business Development

EPI-Q, Inc. EPI-Q, Inc.

Tel: 630.570.5505 Tel: 914.358.3264

Fax: 630.570.5506 Fax: 914.358.3265

Email: mark.jewell@epi-q.com Email: drew.baker@epi-q.com


'/>"/>
SOURCE EPI-Q, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... ... and services based in Aurora, Ohio, has broken ground on a new building ... Research Triangle Park area, this new location solidifies a commitment to business in ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A ... offer a new way to treat the disease. Surviving Mesothelioma has just posted an ... Scientists from several Korean institutions based their mesothelioma study on the fact the Manumycin ...
(Date:5/19/2016)... ... May 19, 2016 , ... KCAS Bioanalytical and Biomarker Services, ... Director, Large Molecule & Biomarker Bioanalysis. , Dr. Siddiqui has more than 15 ... for preclinical and clinical safety programs. “We’ve seen significant demand for, and we ...
(Date:5/18/2016)... 2016 The Biotech industry continues to ... that there are no opportunities ahead. Today, ActiveWallSt.com has on ... THLD ), Seattle Genetics Inc. (NASDAQ: SGEN ... Corp. (NASDAQ: OPHT ). Sign up now to ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s shares gained ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):